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Carcinogenic effects of chemical mixtures were examined with a medium-term liver bioassay for
carcinogens or a multiorgan medium-term bioassay using male F344 rats. In the medium-term
liver bioassay, rats were initially treated with diethyinitrosamine (DEN) at 200 mg/kg body weight,
ip; after 2 weeks they received chemical mixtures such as 10 different heterocyclic amines at
one-tenth or one-hundredth the dose levels used in carcinogenicity studies and the mixtures of
20 different pesticides, each at acceptable daily intake (ADI) levels or a mixture of 100 times ADI
levels. All animals were subjected to two-thirds partial hepatectomy at week 3 and were
sacrificed at week 8. The numbers and areas of glutathione S-transferase placental form (GST-P)
positive foci (preneoplastic lesions in the liver) were compared between respective groups. When
10 heterocyclic amines were mixed in the diet at one-tenth dose level, clear synergism was
observed, but no combined effects were evident with the one-hundredth dose levels. In the
pesticide experiment, treatment of rats with the 20-pesticide mixture at the AD) dose level did
not enhance GST-P-positive foci. In contrast, a mixture of 100 times the ADI significantly
increased those values. In a multiorgan bioassay of 28 weeks, mixtures of 40 high-volume
compounds and 20 pesticides (suspected carcinogens) added together at their respective ADI
levels did not enhance carcinogenesis in any organs initiated by five different carcinogens (DEN,
N-methyinitrosourea, dimethylhydrazine, N-butyl-N-(4-hydroxybutyl)nitrosamine, and dihydroxy-di-
n-propyinitrosamine) in combination. The combination effect of low dietary levels of five
antioxidants, butylated hydroxyanisole, caffeic acid, sesamol, 4-methoxyphenol, and catechol,
were also examined using the multiorgan bioassay. The incidence of forestomach papillomas was
significantly increased only in the combination group and the results indicate that combination of
the five antioxidants can exert additive/synergistic effects on tumorigenesis in the multiorgan
bioassay. These results indicate that chemical mixtures at very low doses did not enhance
preneoplastic lesions synergistically but the mixtures at certain doses show synergism in the
target organ. The medium-term bioassays are particularly useful tools for this purpose.
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Our environment contains a great variety of
carcinogenic factors including naturally
occurring and synthetic carcinogens, radia-
tion, and viruses, all ofwhich have been
speculated to play major roles in the etiology
ofhuman cancers (1). Because humans are
exposed concurrently or sequentially to a
large variety of environmental carcinogens
at only very low individual doses over their
lifetime, a strong possibility exists that
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agents may act in combination to induce
cancers. Therefore, in addition to detecting
carcinogens in our environment, examina-
tion of low-dose combination effects of
such agents is an important area for
research to evaluate human cancer risk.
Many combinations and scenarios are
possible with exposure to multiple chemi-
cals, depending on the mode ofapplication
and whether administration of carcino-
genic and/or noncarcinogenic agents is
simultaneous or sequential. The two-stage
carcinogenesis hypothesis, now generally
accepted as a basic theory of carcinogene-
sis, assumes sequential exposure to initiat-
ing agents and modifiers acting to promote
the process ofneoplasia.
To bridge the disadvantages oflong-term
carcinogenicity tests and in vitro muta-
genicity assays, medium-term bioassays
using preneoplastic lesions as end point
markers have been proposed. A medium-
term liver bioassay for carcinogens and a
multiorgan bioassay can be used for
detecting the effect of chemical mixtures
at low dose levels, as well as detection of




Medium-Term Liver Bioassay for
Carcinogens. Male F344 rats (group 1)
were given a single ip injection of diethyl-
nitrosamine (DEN) (200 mg/kg body
weight) to initiate hepatocarcinogenesis;
after a 2-week recovery period they
received a test compound(s). The experi-
mental protocol for the medium-term
bioassay is shown in Figure 1. Groups 2
and 3 were given DEN alone and saline
control test compound(s), respectively. All
animals were subjected to two-thirds partial
hepatectomy at week 3 and sacrificed
at week 8. Liver splices were fixed in ice-
cold acetone, embedded in paraffin, then
immunohistochemically stained for glu-
tathione S-transferase placental form (GST-
P). Numbers and areas of GST-P-positive
hepatic cell foci larger than 0.2 mm in
diameter as well as the total areas ofthe liver
sections examined were measured using a
color video image processor. Quantitative
values for GST-P positive foci were com-
pared between the chemical-treated group
and the control group. We consider this
model eminently suitable for evaluation of
combined effects of several carcinogenic
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Figure 1. Experimental protocol for medium-term liver
bioassay.
agents (2). Statistical analysis of differences
between means was carried out using the
Student's t-test or the Welch's t-test after
application of the preliminary F-test for
equal variance for each pair. For proportion
data, the Fisher exact probability test was
used. To determine whether the combined
treatments acted additively or synergisti-
cally, one-tail analysis by the modified
Colton's z-test was carried out (3,4).
Experiment I-A
Low-Level Exposure to a Mixture of
HeterocyclicAmines. Heterocyclic amines
produced in foods under normal cooking
conditions are highly mutagenic and induce
carcinogenicity in rodents (5). Humans are
chronically exposed to mixtures of these
agents simultaneously at low dose levels in
the diet (6). Therefore, potential synergism
of 10 heterocyclic amines at various low
doses was evaluated (2,7). The heterocyclic
amines used and each carcinogenic dose
(full dose) were 3-amino-1,4-dimethyl-5H-
pyrido[4,3b]indole ([Trp-P-1] 150 ppm),
2-aminodipyrido [1 ,2a:3',2'-d]imidazol
([Glu-P-2] 500 ppm), 2-amino-3-methyl-
imidazo[4,5-flquinoline ([IQ] 300 ppm),
2-amino-3,4-dimethylimidazo[4,5-f] -
quinoline ([MeIQ] 300 ppm), 2-amino-
3,8-dimethylimidazo[4,5-f]quinoxaline
([MeIQx] 400 ppm), 3-amino-1-methyl-5H-
pyrido[4,3b]indole ([Trp-P-2] 500 ppm),
2-amino-6-methyldipyrido- [1 ,2a:3',2'-
d]imidazol ([Glu-P-1] 500 ppm), 2-amino-
3-methyl-9H-pyrido[2,3-b]indol ([MeAoxC]
800 ppm), 2-amino-9H-pyrido[2,3-b]indol
([AocC] 800 ppm), and 2-amino-1-methyl-
6-phenylimidazo[4,5-b] pyridine ([PhIP]
400 ppm). Purities of heterocyclic amines
were > 99.5% and all 10 heterocyclic
amines were added in the diet at dose lev-
els of one-tenth or one-hundredth of the
dose that was used in the carcinogenicity
study of individual chemicals (3,7). The
results were compared with those from
groups given each chemical at the one-tenth
dose level.
Experiment I-B
Low-Level Exposure to a Mixture of
Twenty Pesticides. Male F344 rats 6 weeks
of age were used. Concentrations of pesti-
cides in the diet (milligrams per kilogram
diet) were calculated based on reported
food intake and body weight data (8).
Food and water were available adlibitum.
Dose selection of each pesticide was
decided on the base of the acceptable daily
intake (ADI) value. The ADI values were
proposed by the Ministry of Health and
Welfare, Japan, with reference to theJoint
Food and Agricultural Organization
(FAO)/World Health Organization
(WHO) Meeting on Pesticide Residues
report (9) (Table 1). The pesticides investi-
gated, along with concentrations in the
diet, their purity, and ADIs (milligrams per
kilogram body weight per day) are listed in
Table 1. All pesticides examined were
organophosphates, except for endosulfan.
The animals were initially given a single
ip injection of DEN. After a 2-week recov-
ery period, the rats received the pesticides
either at the ADI (mixture one, group 1-A)
or at 100 times higher doses (group 1-B) or
were maintained on the basal diet through-
out the experiment (group 2). Groups 3-A
and 3-B were injected with saline and then
fed the mixture one at the ADI and 100
times the ADI, respectively. All animals
were subjected to two-thirds partial hepate-
ctomy at week 3 and sacrificed at week 8.
Liver slices were stained for GST-P.
Numbers and areas of GST-P-positive
hepatic cell foci larger than 0.2 mm in
diameter and the total areas of liver sec-
tions examined were measured using a
video image processor.
Table 1. Data for the 20 pesticides used in experiment I-B.
Present experiment
Chemical ADI, FAO report, Concentration in diet
Pesticide CAS no. class Use mg/kg bw/daya yearb Purity, % for the ADI level, ppm
Acephate 30560-19-1 OP IN 0.03 1990 99.3 0.3
Butamifos 36335-67-8 OP HB 0.0016 - 97.9 0.016
Chlorfenvinphos 470-90-6 OP IN, AC 0.0015C 1971 93.3 0.015
Chlorpyrifos 2921-88-2 OP, HC IN 0.01 1982 99.3 0.1
Dichlorvos 62-73-7 OP IN, AN 0.0033c 1993 98.9 0.033
Dimethoate 60-51-5 OP IN, AC 0.01 1987 99.0 0.1
Edifenphos 17109-49-8 OP FU 0.0025c 1981 95.0 0.025
Endosulfan 115-29-7 OC, HC IN, AC 0.006 1989 98.0 0.06
Etrimfos 38260-54-7 OP, HC IN, AC 0.003 1986 94.0 0.03
Fenitrothion 112-14-5 OP IN 0.005 1988 96.7 0.05
Iprobenfos 26087-47-8 OP FU 0.003 - 94.9 0.03
Isoxathion 18854-01-8 OP IN 0.003 - 95.2 0.03
Malathion 121-75-5 OP IN, AC 0.02 1966 95.4 0.2
Methidathion 950-37-8 OP, HC IN, AC 0.001 1992 92.04 0.01
Pirimiphos-methyl 29232-93-7 OP, HC IN, AC 0.01C 1992 99.7 0.1
Prothiophos 34643-46-4 OP IN 0.0015 - 94.7 0.015
Pyraclofos 77458-01-6 OP IN 0.001 - 98.4 0.01
Tolclofos-methyl 57018-04-9 OP FU 0.064 - 99.5 0.64
Trichlorfon 52-68-9 OP, OC IN 0.01 1978 99.0 0.1
Vamidothion 2275-23-2 OP IN, AC 0.008 1988 99.0 0.08
Abbreviations: AC, acaricide; AN, anthelminthic drug; FU, fungicide; HC, heterocyclic; OC, organochlorine; OP, organophosphate/organothiophosphate; HB, herbicide; IN,
insecticide. 1ADI levels were provided bythe Ministry of Health and Welfare, Japan (9), exceptfor dimethoate, endosulfan, and methidathion, forwhich data were cited from
FAO/WHO(9). bYearrefers to the date ofthe study as published by FAO/WHO (9). cLowerthan the ADI levels from FAO/WHO (9).
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Experiment II
Multiorgan Bioassay. To detect carcino-
genic or modifying potentials of test chem-
icals in multiple organs as well as the liver
for the medium-term period, we also devel-
oped a medium-term multiorgan bioassay
(DMBDD model) (4,10). Figure 2 shows
the experimental protocol of the multi-
organ medium-term bioassay. As initiation,
five known potent carcinogens were given
in combination within the first 4 weeks: a
single ip injection ofDEN at a dose of 100
mg/kg body weight at the start of the
experiment; four ip injections ofN-methyl-
N-nitrosourea (MNU) at a dose of 20
mg/kg body weight on days 2, 5, 8, and
11, and four sc injections of 1,2-dimethyl-
hydrazine (DMH) at a dose of 40 mg/kg
body weight on days 14, 17, 20, and 23,
500 mg/1 N-butyl-N-(4-hydroxybutyl)-
nitrosamine (BBN) in the drinking water
during weeks 1 and 2, and 1000 mg/1 2,2'-
dihydroxy-di- n-propylnitrosamine
(DHPN) in the drinking water during
weeks 3 and 4. After this DMBDD treat-
ment, rats received test chemicals for 24
weeks. Noninitiation controls were injected
ip with saline and subcutaneously with corn
oil and then given pesticide(s). At week 28
of the experiment, all surviving animals
were sacrificed and completely autopsied.
Livers were analyzed for GST-P-positive
foci as described in Experiment I. The main
organs and any macroscopic lesions were
removed and fixed in formalin. The rou-
tinely prepared hematoxylin and eosin sec-
tions were examined for neoplastic and
preneoplastic lesions.
Experiment TI-A
Mixture ofTwenty or Forty Pesticides.









Figure 2. Experimental protocol of multiorgan medium-
term liver bioassay.
chemicals of high-volume production
(mixture one) and 20 chemicals for which
carcinogenicity has been reported or sus-
pected (mixture two). The pesticides and
concentrations (milligrams per kilogram
diet) in mixture one were acephate (0.3),
bendicarb (0.04), bensulide (0.4), bentazone
(0.9), chinomethionat (0.06), chlorobenzi-
late (0.2), chlorpropham (1), chlorpyrifos
(0.1), clofentezine (0.086), cyfluthrin (0.2),
cyhalothrin (0.085), cypermethrin (0.5),
diflubenzuron (0.12), fenarimol (0.1),
fenbutantin oxide (0.3), fenvalerate (0.2),
flucythrinate (0.125), flutolanil (0.8),
glyphosate (1.5), imazalil (0.25), malathion
(0.2), maneb (0.05), mepiquat chloride
(0.75), metalaxyl (0.19), metolachlor
(0.97), metribuzin (0.125), myclobutanil
(0.12), oxamyl (0.2), pendimethalin (0.43),
permethrin (0.48), pirimiphos-methyl
(0.1), propiconazole (0.18), pyrifenox (1),
quinclorac (0.29), sethoxydim (1.4),
thiobencarb (0.09), triadimefon (0.12),
trichlorfon (0.1), vinclozolin (1.215), and
zineb (0.05) Pesticides and concentrations
in mixture two (milligrams per kilogram
diet) were acephate (0.3), amitraz (0.012),
captafol (0.5), clofentezine (0.086), cyper-
methrin (0.5), 2,4-dichlorophenoxyacetic
acid (3), dichlorvos (0.033), dichlobenil
(0.04), dicofol (0.25), fosetly (8.8), glyph-
osate (1.5), mancozeb (0.5), maneb (0.05),
mefolachlor (0.97), permethrin (0.48),
phosmet (0.2), propiconazole (0.18),
propoxur (0.63), triadimefon (0.12), and
trifluralin (0.075).
Possible modifying effects of these
pesticide mixtures on tumorigenesis were
investigated using the DMBDD model.
After the DMBDD treatment, groups of
rats received one ofthe pesticide mixtures
(group 1 received mixture one and group 2
Table 2. Numbers of GST-P-positive foci in the liver of
rats given heterocyclic amines (experiment I-A).
Relative dose levelsa
Chemical 1/1 1/10 1/100
Trp-P-1 49.17 -0.82
Glu-P-2 9.40 -4.73 -
10 65.32 0.87 -
MelQ 17.44 -1.56
MelQx 28.36 -1.77 -
Trp-P-2 5.97 -2.37
Glu-P-1 55.48 5.27 -
MeAaxC 17.93 0.38 -
AaxC 9.42 -4.05 -
PhIP -2.31 -0.10 -
Combination - 42.32 -1.82
aNumbers (no./cm2) are the net values (obtained by
subtracting the background levels) of foci larger than
0.1 mm in diameter.
received mixture two), captafol (1500
mg/kg in the diet) as a positive control
(group 3) (11), or the basal diet (group 4)
for 24 weeks. Rats were sacrificed after
these treatments and multiple organs were
analyzed as described in Experiment I.
Experiment II-B
Mixture of Five Antioxidants in a
Multiorgan Bioassay. The carcinogenicity
of low dietary levels of the antioxidants
butylated hydroxyanisole (BHA), caffeic
acid, sesamol, 4-methoxyphenol (4-MP),
and catechol, known to target the forestom-
ach or glandular stomach, were examined
alone or in combination in a 2-year long-
term experiment and their modifying
effects assessed in a medium-term multi-
organ bioassay model. In the carcinogenic-
ity study, groups of30 to 31 male F344 rats
were treated with 0.4% BHA, 0.4% caffeic
acid, 0.4% sesamol, 0.4% 4-MP, and
0.16% catechol either alone or in combina-
tion for up to 104 weeks and then sacri-
ficed. In the medium-term bioassay, groups
of 10 to 15 male F344 rats were given
DEN, MNU, DMH, BBN, and DHPN
for a total multiple initiation period of 4
weeks. BHA, caffeic acid, sesamol, and 4-
MP, each at doses of0.4 or 0.08%, and cat-
echol at doses of 0.16 or 0.032%, were
administered in the diet either alone or in
combination after completion of the initia-
tion regimen. All surviving animals were
sacrificed at the end ofweek 28, and major
organs were examined histopathologically.
Results
Experiment I-A
When 10 heterocyclic amines were mixed
in the diet at the one-tenth dose level, clear
synergism was observed, but no combined
effects were evident with the one-hun-
dredth dose levels (Table 2) (3). The fact
that synergism clearly was observed at rela-
tively low dose levels is important because
mixtures of these heterocyclic amines may
be generated in cooked food. Although
individual compounds might be without
obvious effects on carcinogenicity, they
may present a hazard risk in combination
at the levels present in food.
Experiment I-B
Data on the numbers and areas ofGST-P-
positive foci per unit area of liver section
with and without DEN initiation are
compared in Table 3. The number of
GST-P-positive foci in group 1-A was
3.36 ± 1.29/cm2 and the area of foci was
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Table 3. Quantitative data forGST-P-positive livercell foci in treated rats(experiment l-B).
GST-P-positive foci
Effective Area,
Group Treatment no. of rats No./cm2 mm2/cm2
1 DEN-ADI mixture 19 3.36+±1.29 0.29±0.15
2 DEN 10OxADI mixture 18 4.51 ±1.64* 0.44±0.20**
3 DEN-basal diet 19 3.50±1.29 0.28±0.13
4 None-ADI mixture 10 0 0
5 None 100xADI mixture 9 0 0
*`**Significantly different from the relevant group value atp<0.05 and p<0.01, respectively.
0.29 ±0.15 mm2/cm2. The levels were
essentially the same as those in the control
group (3.50± 1.29/cm2 and 0.28 ±0.13
mm2/cm2). However, the values obtained
in the 100 times higher ADI mixture
group (group 1-B) (4.51 ± 1.64/cm2 and
0.44 ± 0.20 mm2/cm2) were both signifi-
cantly higher than the control values.
Without the DEN initiation, neither ofthe
treatment schedules induced GST-P-
positive liver cell foci larger than 0.2 mm








Figure 3. Numbers and areas of GST-P-positive liver
cell foci in rats treated with DMBDD followed by 40- or
20-pesticide mixtures. *Significantly different from
basal diet group at p<0.01.
Experiment II-A
In the liver, development ofGST-P-positive
foci was increased by captafol but not mod-
ulated by the mixtures (Figure 3). In the
other organs, captafol showed promotion
effects in the thyroid, whereas the pesticide
mixtures did not influence the neoplastic
development in any organ. No neoplastic
and preneoplastic lesions were observed in
noninitiated groups (groups 3-A to 3-C)
(Table4).
ExperimentII-B
In the carcinogenicity study, slightly
increased incidences offorestomach papillo-
mas were found in the sesamol- (15.8%),
caffeic acid- (14.8%), catechol- (3%), and
4-MP- (11.5%) treated groups as compared
to the basal diet group (0%); a significant
increase was observed with the five antioxi-
dants in combination (42.9%, p<0.001)
(Table 5). In the medium-term multiorgan
bioassay, incidences offorestomach papillo-
mas and/or carcinomas were increased in
Table 4. Incidence oftumors(experiment ll-A).a
DMBDD-treated groupb
Organ and type oftumors 40 pesticides 20 pesticides Captafol Basal diet
Thyroid
Follicular adenoma 2 6 9* 2
C-cell adenoma 1 1 0 0
Nasal cavity
Papilloma 1 0 0 0
Odontoma 0 1 0 0
Lung
Adenoma 4 5 3 5
Carcinoma 1 1 0 2
Oral cavity
Odontoma 0 2 0 0
Esophagus
Squamous cell carcinoma 0 0 1 0
Forestomach
Squamous cell papilloma 3 8 2 4
Squamous cell carcinoma 0 1 1 0
Small intestines
Adenoma 3 1 2 2
Adenocarcinoma 0 2 2 1
Large intestines
Leiornyoma 0 1 0 0
Adenocarcinoma 2 2 6 4
Liver
Hyperplastic nodule 1 0 1 1
Kidney
Nephroblastoma 2 4 7 2
Transitional cell carcinoma 0 1 0 0
Urinary bladder
Transitional cell papilloma 0 1 0 1
Prostate
Leiomyosarcoma 0 1 0 0
Sarcoma 1 1 0 0
Skin/subcutis
Squamous cell papilloma 0 1 0 0
Lipoma 0 1 0 0
Abdominal cavity
Mesothelioma 0 0 1 0
Peripheral nerve
Malignant schwannoma 0 1 0 0
&A few tumors were observed only in the control group: thymic lymphoma (thymus), follicular carcinoma (thyroid),
adenocarcinoma (nasal cavity), adenoma (seminal vesicle), keratoacanthoma (skin), schwannoma (peripheral nerve).
No neoplastic lesions were found in the noninitiated groups. bNumber of animals in groups of 40 and 20 pesticides,
captafol, and basal dietwere 20, 20, 19, and 20, respectively. *Significantly differentfrom control group atp<0.05.
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Table 5. Histopathologic findings in the forestomach of rats treated with DMBDD followed by antioxidants either alone or in combination (experiment Il-B).
PN hyperplasia Papilloma Carcinoma
Treatment Rats, no. Incidence, % Multiplicity, no./slide Incidence, % Multiplicity, no./slide incidence, %
Combination 28 17(61)** 1.04+1.05** 12(43)** 0.93±1.31** 1(4)
BHA 26 0 - 0 0
4-Methoxyphenol 26 8 (31)* 0.31 0.46 3 (12) 0.19 0.62 0
Caffeic acid 27 17 (63)** 1.11 +1.13** 4(15) 0.19±0.47* 0
Sesamol 19 5 (26) 0.37 0.67 3(16) 0.21 0.52 0
Catechol 29 6(21) 0.69±2.73 1(3) 0.03±0.18 0
Basal diet 25 1(4) 0.08±0.39 0(4) - 0
PN, papillary or nodular. S **Significantly different from basal diet group at p<0.05 and p<0.01, respectively.
each high-dose group, but additive or
synergistic effects were not found in the
combination group. In the low-dose group,
the incidence of forestomach papillomas
was significantly increased only in the com-
bination group. With regard to other
organs, the incidence ofcolon tumors was
significantly decreased only in the high-
dose combination group. The results indi-
cate that even at relatively low dose levels,
phenolic compounds can exert an additive/
synergistic effect on carcinogenesis (12).
Discussion
In the liver model, the ADI mixture of
organophosphorus pesticides exerted no
effects on development ofliver preneoplas-
tic foci initiated by DEN, although the
100 times higher dose demonstrated
lesion-promoting potential (8,13,14). In
the multiorgan model, the ADI mixtures of
40 (mixture two) or 20 (mixture three) pes-
ticides demonstrated no tumor-promoting
potential in any organ or tissue (13,14).
Captafol, on the other hand, exerted
apparent tumor-promoting effects in the
liver, thyroid, and kidney, although the
dose level was not comparable to the mix-
tures. The protocol has been developed in
our laboratory over the last 15 years (10).
Quantitative analysis of GST-P-positive
foci has been established. The multiorgan
method has been developed to supplement
the liver model and is also a useful method
for rapid detection of carcinogens at the
whole-body level (4,10).
With a safety factor approach, acceptable
exposure levels such as ADIs are usually
determined by dividing the no observed
effect level from laboratory-based chronic
toxicity tests by an appropriately chosen
safety factor. The safety factor used for
ADI by the Japanese Ministry of Health
and Welfare and the FAO/WHO is usu-
ally 100, but WHO expert committees
have used figures ranging from 10 to
2000 (15). Our experimental results indi-
cate that this procedure is indeed appro-
priate and acceptable for risk evaluation
at present. Furthermore, the chance of
exposure to so many pesticides (20 or 40
chemicals) in concert might in practice be
low (16).
Because most human cancers may be
caused by trace environmental factors, it is
of increasing importance that combined
effects of chemicals at relatively low doses
be examined. The medium-term bioassays
used in these studies are particularly useful
methods for this matter.
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